Fundraising FoxMagenta Therapeutics
Cambridge, US · Founded 2015 · Delaware corporation · 10 known investors
Find your way into Magenta Therapeutics
Sign up to see every warm intro you have to Magenta Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Magenta Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Magenta Therapeutics was founded in 2015 by David Scadden.
Board
Investors · 10
How we know: GV (Google Ventures)'s portfolio page · funding news · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: funding news · biocentury.com · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · biocentury.com · Not right? Tell us
How we know: funding news · open dataset · 5k.vc investor directory · Not right? Tell us
Also in the syndicate · 3
Reported raises · per SEC filings
Form D private placements$116M disclosed across 3 rounds · 2016–2018
▶$52.3MraisedApr 2018 · 23 investors · BiotechnologyRule 506(b)
- Zoran ZdraveskiExecutive Officer
- Blake ByersDirector
- Jason GardnerExecutive Officer, Director
- Thomas DanielDirector
- Amy RonnebergDirector
- David ScaddenDirector
- Jeffrey AlbersDirector
- Michael BonneyDirector
- Bruce BoothDirector
- Alexis BorisyDirector
- John DavisExecutive Officer
- Offering amount
- $52.3M
- Amount sold
- $52.3M
- First sale
- Apr 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$46MraisedMay 2017 · 13 investors · BiotechnologyRule 506(b)
- Bastiano SannaExecutive Officer
- Thomas DanielDirector
- Michael BonneyDirector
- Bruce BoothDirector
- Alexis BorisyDirector
- Jason GardnerExecutive Officer, Director
- Blake ByersDirector
- David ScaddenDirector
- Offering amount
- $50M
- Amount sold
- $46M
- First sale
- Apr 2017
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$17.7MraisedNov 2016 · 13 investors · BiotechnologyRule 506(b)
- David ScaddenDirector
- Michael BonneyDirector
- Bruce BoothDirector
- Alexis BorisyDirector
- Bastiano SannaExecutive Officer
- Thomas DanielDirector
- Jason GardnerExecutive Officer, Director
- Offering amount
- $48.7M
- Amount sold
- $17.7M
- First sale
- Nov 2016
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
4 people who came through Magenta Therapeutics went on to found or lead other companies.
Frequently asked questions
- Who founded Magenta Therapeutics?
- Magenta Therapeutics was founded by David Scadden in 2015.
- Who are Magenta Therapeutics's investors?
- Magenta Therapeutics's investors include GV (Google Ventures), Access Industries, Alphabet, Atlas Venture, Casdin Capital, EcoR1 Capital, Third Rock Ventures.
- How much funding has Magenta Therapeutics raised?
- Magenta Therapeutics has disclosed $116M raised across 3 rounds.
- Where is Magenta Therapeutics headquartered?
- Magenta Therapeutics is headquartered in Cambridge, US.